GIP/GLP-1
Sort by:
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
FEATURING
Ken Fujioka
- 14,889 views
- November 28, 2022
- 72
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
- 7,715 views
- August 14, 2023
- 112
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
FEATURING
Steven Nissen
- 5,620 views
- July 26, 2023
- 61
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
- 4,129 views
- September 27, 2023
- 23
Stanford Medicine
What's the Ideal Therapy for Obesity?
FEATURING
Aaron Yeoh
- 3,615 views
- June 13, 2023
- 21
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,383 views
- August 29, 2023
- 19
UT Health San Antonio School of Medicine
Effective Treatment of T2DM Requires Combination Therapy
FEATURING
Ralph DeFronzo
- 2,505 views
- August 30, 2023
- 20
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,351 views
- November 30, 2023
- 20
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
- 2,149 views
- January 26, 2024
- 40
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
- 2,104 views
- January 29, 2024
- 36
Silva Arslanian
Once-Weekly Subcutaneous Semaglutide 2.4 mg in Adolescents with Obesity
- 2,050 views
- February 9, 2023
- 13
Houston Methodist DeBakey Heart and Vascular Center
Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?
FEATURING
Kershaw Patel
- 1,913 views
- November 15, 2022
- 8
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,706 views
- November 21, 2023
- 19
Scripps Health
Obesity and Diabetes Pharmacotherapy: Are You Ready for GLP-1 Agonists?
FEATURING
Samantha Harris
- 1,504 views
- June 21, 2023
- 11
Primary Care Education Consortium
Treatment Approaches for Obesity: Pharmacologic
FEATURING
Robert Kushner
- 1,413 views
- February 27, 2024
- 7
ADA 2023 Insights
ADA 2023 Insights: Role for Amylin in Monotherapy and Combination Therapy for Obesity
FEATURING
David Lau
- 1,371 views
- July 14, 2023
- 11